WeVote

Bill

Bill

LD 2146

An Act To Increase Access To Critical Vaccinations

132nd Legislature (2025-2026) Introduced by Donna Bailey and 4 co-sponsors

Maine bill expands access to vaccinations through legislative mechanisms, though divided committee opinions suggest disagreement over scope, funding, and implementation approach.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · LD 2146

Legislative bill overview

LD 2146 aims to expand vaccination access in Maine through legislative mechanisms, with bipartisan sponsorship indicating broad intent to address immunization rates or coverage gaps. The bill received a divided committee report and was reported out with amendments or ought-not-to-pass recommendations as of April 2026, suggesting significant debate over implementation.

Why is this important

Vaccination access directly affects public health outcomes, disease prevention, and healthcare costs. Barriers to vaccination—whether financial, geographic, or logistical—can create vulnerable populations and undermine herd immunity thresholds, making this a foundational public health issue.

Potential points of contention

  • Scope of "critical" vaccines: Defining which vaccines qualify may reflect disagreements over CDC recommendations versus state-mandated schedules, or vaccine types (routine childhood vs. adult vs. specialty vaccines)
  • Funding mechanisms and costs: Whether expanded access requires new appropriations, mandates to insurers, or restructuring of existing programs affects budget impacts and stakeholder support
  • Mandate vs. voluntary framework: The divided committee report suggests disagreement over whether the bill incentivizes access or requires/mandates certain vaccination practices, which carries different constitutional and practical implications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.